Usability and accuracy of the Hormona at-home perimenopause test kit and mobile app

Clinical performance and usability assessment of hormona perimenopause

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN13282875

Enrollment

Registered

2026-01-13

Start date

2026-01-01

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Perimenopause and menopause Other

Interventions

The study is designed to assess the performance of the Hormona Perimenopause self-test system, as well as the usability and comprehension of the test kit and mobile app among a representative group of

Eligibility

Sex/Gender

Female

Age

40 Years to 55 Years

Inclusion criteria

Inclusion criteria: 1. Age between 40 and 55 years. 2. Own a compatible smartphone (Android 6.0 or later, or iOS 13.4 or later) 3. Located in England and Scotland

Exclusion criteria

Exclusion criteria: 1. Currently pregnant 2. Currently breastfeeding 3. Using hormonal contraceptives (including oral, implant, patch, or IUD) 4. Receiving hormone replacement therapy (HRT) 5. Diagnosed with any of the following conditions: Hormone-related disorders (e.g. PCOS, thyroid dysfunction), mood disorders (e.g. depression, bipolar disorder), dementia or significant cognitive impairment, kidney, liver, or cardiovascular disease

Countries

England, Scotland, United Kingdom

Contacts

Public ContactAnna Targonskaya

anna@hormona.io-

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Jun 29, 2026